跳至主要内容
临床试验/CTRI/2018/05/013602
CTRI/2018/05/013602尚未招募1/2 期

A clinical study to evaluate the efficacy of subidhabala khand in garbhini chardi w.s.r.to emesis gravidarum

Parul Institute of Ayurved and Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年5月15日最近更新:

试验速览

阶段
1/2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Vomiting

研究概览

简要总结

Hypothesis :- Subidhabala khand has effective on Garbhini chardi

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
20.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • Patient diagnosed as Garbhini chardi (emisis gravidarum) in first Trimester of Pregnancy.
  • Both Primi and Multi gravida.

排除标准

  • Patients in whom chardi in second and Third Trimester, hyper Emesis gravidorum, twin Pregnancy and Vesicular mol, and Due to other systemic disorders like Peptic Ulcer, Appendicitis etc.

结局指标

主要结局

Vomiting

时间窗: 30 Days

Anorexia

时间窗: 30 Days

Nausea

时间窗: 30 Days

次要结局

  • Decereasing Vomiting along Nausea and Anorexia(30 Days)

研究者

发起方
Parul Institute of Ayurved and Hospital
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验